Company intelligence / Profile preview

410 Medical

Durham, North Carolina, United States410medical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, LifeFlow Fluid Infuser, received FDA clearance in 2016 and launched in 2017. It enables rapid delivery of fluids for critically ill patients. The next-generation product, LifeFlow PLUS, received FDA clearance in September 2020 for use with blood and blood products as well as crystalloids. Both products are marketed to hospitals and EMS groups across the US; clinical adoption has expanded to over three dozen health systems nationwide. Published data support improved speed of fluid resuscitation.

Therapeutic areas: HematologyCardiovascularInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

LifeFlow

Commercial

Indications: Sepsis, Trauma, Hypotension, Shock

1 more asset in the full pipeline.

Request access →

Partnerships

North Carolina Biotechnology Center (support/funding)

Beyond the preview

Go deeper on 410 Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 410 Medical.

Explore the full profile